On ECHEMI
Home > Drugs > Mucopolysaccharidosis type VI
Mucopolysaccharidosis type VI
This type is also called Maroteaux-Lamy syndrome and multiple dystrophic dwarfism. It is also an autosomal recessive hereditary disease. It is characterized by short stature, corneal opacity, but normal intelligence. This type of mucopolysaccharidosis was first discovered by Maroteaux (1963) and is an independent disease different from other types of mucopolysaccharidosis.
Related Drugs
Intestinal polysaccharide tablets
Indication: Used for coronary heart disease and atherosclerosis.
Manufacturer:

Shanghai Yan'an Pharmaceutical Co.

Intestinal polysaccharide tablets
Indication: Used for coronary heart disease and atherosclerosis.
Manufacturer:

Gansu Puerkang Pharmaceutical.,Ltd

Intestinal polysaccharide tablets
Indication: Used for coronary heart disease and atherosclerosis.
Manufacturer:

Gansu Puerkang Pharmaceutical.,Ltd

Palm chloramphenicol (type B) tablets
Indication: 1. Typhoid and other Salmonella infections: It is the drug of choice for typhoid and paratyphoid caused by sensitive strains. It is generally not suitable for gastroenteritis caused by Salmonella infection. It can still be used if the condition is serious and there is a possibility of septicemia. 2. Mild to moderate anaerobic infections, such as infections caused by Bacteroides fragilis. It is especially suitable for those with lesions involving the central nervous system. It can be used in combination with aminoglycoside antibiotics to treat abdominal and pelvic infections to control coexisting aerobic and anaerobic infections. 3. Rickettsial infections can be used to treat Q fever, Rocky Mountain spotted fever, endemic typhus, etc.
Manufacturer:

Yili Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.